ID
25292
Description
Study ID: 101468/191 Clinical Study ID: SKF-101468/191 Study Title:A 12 Week, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Efficacy, Safety and Tolerability of Ropinirole in Subjects with Restless Legs Syndrome (RLS) Suffering from Periodic Leg Movements of Sleep (PLMS) Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: Sponsor: GlaxoSmithKline Collaborators: N/A Phase: phase 3 Study Recruitment Status: Completed Generic Name: ropinirole Trade Name: Requip Study Indication: Restless Legs Syndrome
Keywords
Versions (1)
- 8/31/17 8/31/17 -
Uploaded on
August 31, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)
GSK Ropinirole in Subjects with Restless Legs Syndrome 101468/191 Baseline (Form 2)
Description
Orthostatic Vital Signs
Description
Pre-Dose (Reading 1) systolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
Pre-Dose (Reading 1) diastolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
Pre-Dose (Reading 1) Pulse after 10 minutes semi-supine
Data type
integer
Measurement units
- beats/min
Description
Pre-Dose (Reading 1) systolic blood pressure after erect for 1 minute
Data type
integer
Description
Pre-Dose (Reading 1) diastolic blood pressure after erect for 1 minute
Data type
integer
Description
Pre-Dose (Reading 1) pulse after erect for 1 minute
Data type
integer
Measurement units
- beats/min
Description
Pre-Dose (Reading 2) systolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
Pre-Dose (Reading 2) diastolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
Pre-Dose (Reading 2) pulse after 10 minutes semi-supine
Data type
integer
Measurement units
- beats/min
Description
Pre-Dose (Reading 2) systolic blood pressure after erect for 1 minute
Data type
integer
Description
Pre-Dose (Reading 2) diastolic blood pressure after erect for 1 minute
Data type
integer
Description
Pre-Dose (Reading 2) pulse after erect for 1 minute
Data type
integer
Measurement units
- beats/min
Description
2 hours Post-Dose (Reading 1) systolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
2 hours Post-Dose (Reading 1) diastolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
2 hours Post-Dose (Reading 1) pulse after 10 minutes semi-supine
Data type
integer
Measurement units
- beats/min
Description
2 hours Post-Dose (Reading 1) systolic blood pressure after erect for 1 minute
Data type
integer
Description
2 hours Post-Dose (Reading 1) diastolic blood pressure after erect for 1 minute
Data type
integer
Description
2 hour Post-Dose (Reading 1) pulse after erect for 1 minute
Data type
integer
Description
2 hours Post-Dose (Reading 2) systolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
2 hours Post-Dose (Reading 2) diastolic blood pressure after 10 minutes semi-supine
Data type
integer
Description
2 hours Post-Dose (Reading 2) pulse after 10 minutes semi-supine
Data type
integer
Measurement units
- beats/min
Description
2 hours Post-Dose (Reading 2) systolic blood pressure after erect for 1 minute
Data type
integer
Description
2 hours Post-Dose (Reading 2) diastolic blood pressure after erect for 1 minute
Data type
integer
Description
2 hour Post-Dose (Reading 2) pulse after erect for 1 minute
Data type
integer
Measurement units
- beats/min
Description
Baseline PLMI
Description
Polysomnography
Description
Baseline Inclusion Criteria
Description
1. Subjects with a total score >15 on the RLS Scale at Baseline.
Data type
boolean
Description
If the above question has been answered "No" exclude the patient from the study and complete the Patient Continuation/Withdrawal page behind the Basline Visit Section.
Data type
boolean
Description
Baseline Exclusion Criteria
Description
secondary RLS
Data type
boolean
Description
Augmentation
Data type
boolean
Description
Subjects having clinically significant abnormal laboratory
Data type
boolean
Description
Medication affecting RLS or sleep
Data type
text
Description
If any of the above questions have been answered "Yes" exclude the patient from the study and complete the Patient Continuation/Withdrawal page behind the Baseline Visit Section.
Data type
boolean
Description
RLS rating scales
Description
Vital signs
Description
Pulse
Data type
integer
Measurement units
- beats/min
Description
Sitting Blood Pressure (systolic)
Data type
integer
Description
Sitting Blood Pressure diastolic
Data type
integer
Description
Concomitant Medication
Description
Medical Procedures
Description
Baseline Signs and Symptoms (or events, or diagnoses)
Description
Baseline event
Data type
text
Description
Onset Date and Time
Data type
datetime
Description
If ongoing please leave blank
Data type
datetime
Description
Outcome
Data type
text
Description
Event Course
Data type
text
Description
Intensity (maximum)
Data type
text
Description
Relationship to study procedures performed prior to randomization
Data type
text
Description
If "Yes", record details in Prior and Concomitant Medication section if appropriate.
Data type
boolean
Description
Patient withdrawn due to event
Data type
boolean
Description
Baseline Employment Status
Description
Employment status
Data type
text
Description
Part-time employment
Data type
float
Measurement units
- hours/week
Description
Volunteer/Unpaid work
Data type
integer
Description
Patient´s occupation
Data type
text
Description
Ramos Randomization and dispensing
No comments